Back
Vanguard S&P Mid-Cap 400 Value ETF Vs. PTC Therapeutics Industry Stock Comparison
Buy
60
IVOV
Vanguard S&P Mid-Cap 400 Value ETF
Last Price:
96.19
Seasonality Move:
6.89%
Sell
40
PTCT
PTC Therapeutics
Last Price:
37.52
Seasonality Move:
3.92%
Buy
60
Vanguard S&P Mid-Cap 400 Value ETF (IVOV)
is a Buy
Is Vanguard S&P Mid-Cap 400 Value ETF a Buy, Sell or Hold?
- The current Vanguard S&P Mid-Cap 400 Value ETF [IVOV] share price is $95.69. The Score for IVOV is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- IVOV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $37.56. The Score for PTCT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IVOV Stock Price Chart
What is Vanguard S&P Mid-Cap 400 Value ETF's stock price today?
-
The Vanguard S&P Mid-Cap 400 Value ETF share price today is $95.69
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IVOV is experiencing slight selling pressure.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $37.56
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing slight selling pressure.
IVOV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.01 | Buy |
| Relative Strength Index (14 RSI): | 62.5 | Buy |
| Chaikin Money Flow: | -5219 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (91.8 - 95.18) | Buy |
| Bollinger Bands (100): | (87.59 - 93.09) | Buy |
PTCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.06 | Buy |
| Relative Strength Index (14 RSI): | 69.28 | Buy |
| Chaikin Money Flow: | -221691 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.67 - 36.49) | Buy |
| Bollinger Bands (100): | (31.89 - 36.41) | Buy |
IVOV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 95.17 | Buy |
| 20-day SMA: | 93.37 | Buy |
| 50-day SMA: | 92.27 | Buy |
| 200-day SMA: | 88.36 | Buy |
| 8-day EMA: | 94.92 | Buy |
| 20-day EMA: | 93.86 | Buy |
| 50-day EMA: | 92.34 | Buy |
| 200-day EMA: | 88.3 | Buy |
PTCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.67 | Buy |
| 20-day SMA: | 34.47 | Buy |
| 50-day SMA: | 33.72 | Buy |
| 200-day SMA: | 31.08 | Buy |
| 8-day EMA: | 36.52 | Buy |
| 20-day EMA: | 35.25 | Buy |
| 50-day EMA: | 34.22 | Buy |
| 200-day EMA: | 32.66 | Buy |
Vanguard S&P Mid-Cap 400 Value ETF Earnings Growth & IVOV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.67 per share, an increase this year of $0.38 per share, and an increase next year of $0.67 per share.
Vanguard S&P Mid-Cap 400 Value ETF Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
PTC Therapeutics Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||